Literature DB >> 23138349

Generation of human induced pluripotent stem cells from urine samples.

Ting Zhou1, Christina Benda, Sarah Dunzinger, Yinghua Huang, Jenny Cy Ho, Jiayin Yang, Yu Wang, Ya Zhang, Qiang Zhuang, Yanhua Li, Xichen Bao, Hung-Fat Tse, Johannes Grillari, Regina Grillari-Voglauer, Duanqing Pei, Miguel A Esteban.   

Abstract

Human induced pluripotent stem cells (iPSCs) have been generated with varied efficiencies from multiple tissues. Yet, acquiring donor cells is, in most instances, an invasive procedure that requires laborious isolation. Here we present a detailed protocol for generating human iPSCs from exfoliated renal epithelial cells present in urine. This method is advantageous in many circumstances, as the isolation of urinary cells is simple (30 ml of urine are sufficient), cost-effective and universal (can be applied to any age, gender and race). Moreover, the entire procedure is reasonably quick--around 2 weeks for the urinary cell culture and 3-4 weeks for the reprogramming--and the yield of iPSC colonies is generally high--up to 4% using retroviral delivery of exogenous factors. Urinary iPSCs (UiPSCs) also show excellent differentiation potential, and thus represent a good choice for producing pluripotent cells from normal individuals or patients with genetic diseases, including those affecting the kidney.

Entities:  

Mesh:

Year:  2012        PMID: 23138349     DOI: 10.1038/nprot.2012.115

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  54 in total

1.  Copy number variation and selection during reprogramming to pluripotency.

Authors:  Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

2.  Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.

Authors:  Tomohisa Seki; Shinsuke Yuasa; Keiichi Fukuda
Journal:  Nat Protoc       Date:  2012-03-15       Impact factor: 13.491

3.  Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.

Authors:  Hua Liu; Zhaohui Ye; Yonghak Kim; Saul Sharkis; Yoon-Young Jang
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

4.  Immunogenicity of induced pluripotent stem cells.

Authors:  Tongbiao Zhao; Zhen-Ning Zhang; Zhili Rong; Yang Xu
Journal:  Nature       Date:  2011-05-13       Impact factor: 49.962

5.  Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system.

Authors:  A Dörrenhaus; J I Müller; K Golka; P Jedrusik; H Schulze; W Föllmann
Journal:  Arch Toxicol       Date:  2000-12       Impact factor: 5.153

6.  Culture of urinary cells.

Authors:  F Herz
Journal:  Birth Defects Orig Artic Ser       Date:  1980

7.  Human epithelial cells cultured from urine: growth properties and keratin staining.

Authors:  J S Felix; T T Sun; J W Littlefield
Journal:  In Vitro       Date:  1980-10

8.  Generation of human-induced pluripotent stem cells.

Authors:  In-Hyun Park; Paul H Lerou; Rui Zhao; Hongguang Huo; George Q Daley
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

9.  Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.

Authors:  Chunliang Li; Junmei Zhou; Guilai Shi; Yu Ma; Ying Yang; Junjie Gu; Hongyao Yu; Shibo Jin; Zhe Wei; Fang Chen; Ying Jin
Journal:  Hum Mol Genet       Date:  2009-08-13       Impact factor: 6.150

10.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

View more
  195 in total

Review 1.  Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva.

Authors:  Emilie Barruet; Edward C Hsiao
Journal:  Bone       Date:  2017-07-14       Impact factor: 4.398

Review 2.  An experimental approach to the generation of human embryonic stem cells equivalents.

Authors:  Katarzyna Skowron; Marcin Tomsia; Piotr Czekaj
Journal:  Mol Biotechnol       Date:  2014-01       Impact factor: 2.695

Review 3.  Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives.

Authors:  Shikhar Aggarwal; Aldo Moggio; Benedetta Bussolati
Journal:  Stem Cells Transl Med       Date:  2013-10-28       Impact factor: 6.940

4.  Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector.

Authors:  Arun Sharma; Michael Mücke; Christine E Seidman
Journal:  Curr Protoc Mol Biol       Date:  2018-04

Review 5.  Concise review: modeling central nervous system diseases using induced pluripotent stem cells.

Authors:  Xianmin Zeng; Joshua G Hunsberger; Anton Simeonov; Nasir Malik; Ying Pei; Mahendra Rao
Journal:  Stem Cells Transl Med       Date:  2014-11-03       Impact factor: 6.940

6.  Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.

Authors:  Xuan Guan; David L Mack; Claudia M Moreno; Jennifer L Strande; Julie Mathieu; Yingai Shi; Chad D Markert; Zejing Wang; Guihua Liu; Michael W Lawlor; Emily C Moorefield; Tara N Jones; James A Fugate; Mark E Furth; Charles E Murry; Hannele Ruohola-Baker; Yuanyuan Zhang; Luis F Santana; Martin K Childers
Journal:  Stem Cell Res       Date:  2013-12-23       Impact factor: 2.020

7.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

8.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

Review 9.  Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience.

Authors:  Jerome Mertens; Maria C Marchetto; Cedric Bardy; Fred H Gage
Journal:  Nat Rev Neurosci       Date:  2016-05-19       Impact factor: 34.870

Review 10.  Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.

Authors:  Alison E Mungenast; Sandra Siegert; Li-Huei Tsai
Journal:  Mol Cell Neurosci       Date:  2015-12-04       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.